LIFE SCIENCES PARTNERS
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe's largest and most experienced specialist life-science investors.
LIFE SCIENCES PARTNERS
Industry:
Biotechnology Finance
Founded:
1998-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Font Awesome Domain Not Resolving Euro Amazon IPv6 Cloudflare JS
Similar Organizations
Inkef
Inkef focuses on early-stage venture investing in European companies active in technology and healthcare.
Scottish Enterprise
Scottish Enterprise is Scotland's main economic, enterprise, innovation and investment agency.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-23 | eTheRNA immunotherapies | Life Sciences Partners investment in Series B - eTheRNA immunotherapies | 39 M EUR |
| 2022-06-13 | ImCheck Therapeutics | Life Sciences Partners investment in Series C - ImCheck Therapeutics | 96 M EUR |
| 2022-06-08 | Ariceum Therapeutics | Life Sciences Partners investment in Series A - Ariceum Therapeutics | 25 M EUR |
| 2022-02-09 | Perfuze | Life Sciences Partners investment in Series A - Perfuze | 22.5 M EUR |
| 2021-12-16 | ViCentra | Life Sciences Partners investment in Series C - ViCentra | 65 M EUR |
| 2021-12-02 | AviadoBio | Life Sciences Partners investment in Series A - AviadoBio | 58.6 M GBP |
| 2021-10-26 | DNA Script | Life Sciences Partners investment in Series C - DNA Script | 165 M USD |
| 2021-10-22 | Egle Therapeutics | Life Sciences Partners investment in Series A - Egle Therapeutics | 40 M EUR |
| 2021-10-14 | OneProjects | Life Sciences Partners investment in Series A - OneProjects | 8 M USD |
| 2021-09-16 | Amolyt Pharma | Life Sciences Partners investment in Series B - Amolyt Pharma | 80 M USD |